The role of interleukin-9 in lymphoma

References

• Yang YC, Ricciardi S, Ciarletta A, et al. Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40. Blood 1989;74: 1880–1884.
   PubMed Web of Science ®Google Scholar
• Noelle RJ, Nowak EC. Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 2010;10:683–687.
   PubMed Web of Science ®Google Scholar
• van Leeuwen BH, Martinson ME, Webb GC, et al. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood 1989;73:1142–1148.
   PubMed Web of Science ®Google Scholar
• Stassen M, Klein M, Becker M, et al. p38 MAP kinase drives the expression of mast cell-derived IL-9 via activation of the transcription factor GATA-1. Mol Immunol 2007;44:926–933.
   PubMed Web of Science ®Google Scholar
• Chen J, Petrus M, Bryant BR, et al. Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism. Blood 2008;111: 5163–5172.
   PubMed Web of Science ®Google Scholar
• Refaat A, Zhou Y, Suzuki S, et al. Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9. J Biol Chem 2011;286:21092–21099.
   PubMed Web of Science ®Google Scholar
• Chang HC, Sehra S, Goswami R, et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 2010;11:527–534.
   PubMed Web of Science ®Google Scholar
• Staudt V, Bothur E, Klein M, et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010;33:192–202.
   PubMed Web of Science ®Google Scholar
• Renauld JC, Druez C, Kermouni A, et al. Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc Natl Acad Sci USA 1992;89:5690–5694.
   PubMed Web of Science ®Google Scholar
• Demoulin JB, Uyttenhove C, Lejeune D, et al. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells. Cancer Res 2000;60:3971–3977.
   PubMed Web of Science ®Google Scholar
• Zhu YX, Sun HB, Tsang ML, et al. Critical cytoplasmic domains of human interleukin-9 receptor alpha chain in interleukin-9-mediated cell proliferation and signal transduction. J Biol Chem 1997;272:21334–21340.
   PubMed Web of Science ®Google Scholar
• Hornakova T, Staerk J, Royer Y, et al. Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers. J Biol Chem 2009;284:6773–6781.
   PubMed Web of Science ®Google Scholar
• Demoulin JB, Louahed J, Dumoutier L, et al. MAP kinase activation by interleukin-9 in lymphoid and mast cell lines. Oncogene 2003;22:1763–1770.
   PubMed Web of Science ®Google Scholar
• Xiao H, Yin T, Wang XY, et al. Specificity of interleukin-2 receptor gamma chain superfamily cytokines is mediated by insulin receptor substrate-dependent pathway. J Biol Chem 2002;277:8091–8098.
   PubMed Web of Science ®Google Scholar
• Merz H, Houssiau FA, Orscheschek K, et al. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 1991;78:1311–1317.
   PubMed Web of Science ®Google Scholar
• Nagato T, Kobayashi H, Kishibe K, et al. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients. Clin Cancer Res 2005;11:8250–8257.
   PubMed Web of Science ®Google Scholar
• Fischer M, Bijman M, Molin D, et al. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma. Leukemia 2003;17:2513–2516.
   PubMed Web of Science ®Google Scholar
• Bittner C, Merz H, Krokowski M, et al. [New immunotherapeutic approaches for the treatment of anaplastic large cell lymphoma in a mouse model]. Verh Dtsch Ges Pathol 2000;84:187–198.
   PubMedGoogle Scholar
• Renauld JC, van der Lugt N, Vink A, et al. Thymic lymphomas in interleukin 9 transgenic mice. Oncogene 1994;9:1327–1332.
   PubMed Web of Science ®Google Scholar
• Merz H, Lange K, Nadrowitz R, et al. [Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice]. Verh Dtsch Ges Pathol 2003;87:224–231.
   PubMedGoogle Scholar
• Vink A, Renauld JC, Warnier G, et al. Interleukin-9 stimulates in vitro growth of mouse thymic lymphomas. Eur J Immunol 1993;23: 1134–1138.
   PubMed Web of Science ®Google Scholar
• Gruss HJ, Brach MA, Drexler HG, et al. Interleukin 9 is expressed by primary and cultured Hodgkin and Reed–Sternberg cells. Cancer Res 1992;52:1026–1031.
   PubMed Web of Science ®Google Scholar
• Qiu L, Lai R, Lin Q, et al. Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells. Blood 2006;108:2407–2415.
   PubMed Web of Science ®Google Scholar
• Renauld JC, Vink A, Louahed J, et al. Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 1995;85:1300–1305.
   PubMed Web of Science ®Google Scholar
• Shang Y, Kakinuma S, Amasaki Y, et al. Aberrant activation of interleukin-9 receptor and downstream Stat3/5 in primary T-cell lymphomas in vivo in susceptible B6 and resistant C3H mice. In Vivo 2008;22:713–720.
   PubMed Web of Science ®Google Scholar
• Lemoli RM, Fortuna A, Tafuri A, et al. Interleukin-9 in human myeloid leukemia cells. Leuk Lymphoma 1997;26:563–573.
   PubMed Web of Science ®Google Scholar
• Fontaine RH, Cases O, Lelievre V, et al. IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ 2008;15:1542–1552.
   PubMed Web of Science ®Google Scholar
• Singhera GK, MacRedmond R, Dorscheid DR. Interleukin-9 and -13 inhibit spontaneous and corticosteroid induced apoptosis of normal airway epithelial cells. Exp Lung Res 2008;34:579–598.
   PubMed Web of Science ®Google Scholar
• Carbone A, Gloghini A, Cabras A, et al. The germinal centre-derived lymphomas seen through their cellular microenvironment. Br J Haematol 2009;145:468–480.
   PubMed Web of Science ®Google Scholar
• Molin D, Edstrom A, Glimelius I, et al. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol 2002;119:122–124.
   PubMed Web of Science ®Google Scholar
• Hedstrom G, Berglund M, Molin D, et al. Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma. Br J Haematol 2007;138:68–71.
   PubMed Web of Science ®Google Scholar
• Taskinen M, Karjalainen-Lindsberg ML, Leppa S. Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP. Blood 2008;111: 4664–4667.
   PubMed Web of Science ®Google Scholar
• Stassen M, Arnold M, Hultner L, et al. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J Immunol 2000;164: 5549–5555.
   PubMed Web of Science ®Google Scholar
• Wiener Z, Falus A, Toth S. IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice. Cytokine 2004;26:122–130.
   PubMed Web of Science ®Google Scholar
• Matsuzawa S, Sakashita K, Kinoshita T, et al. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol 2003;170:3461–3467.
   PubMed Web of Science ®Google Scholar
• Renauld JC, Kermouni A, Vink A, et al. Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J Leukoc Biol 1995;57:353–360.
   PubMed Web of Science ®Google Scholar
• Hultner L, Druez C, Moeller J, et al. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol 1990;20:1413–1416.
   PubMed Web of Science ®Google Scholar
• Townsend JM, Fallon GP, Matthews JD, et al. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000;13:573–583.
   PubMed Web of Science ®Google Scholar
• Tzankov A, Meier C, Hirschmann P, et al. Correlation of high numbers of intratumoral FOXP3 + regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 2008; 93:193–200.
   PubMed Web of Science ®Google Scholar
• Lu LF, Lind EF, Gondek DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006;442: 997–1002.
   PubMed Web of Science ®Google Scholar
• Nowak EC, Weaver CT, Turner H, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 2009;206:1653–1660.
   PubMed Web of Science ®Google Scholar
• Smith SE, Hoelzinger DB, Dominguez AL, et al. Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses. Cancer Immunol Immunother 2011;60:1775–1787.
   PubMed Web of Science ®Google Scholar
• Elyaman W, Bradshaw EM, Uyttenhove C, et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3 + natural regulatory T cells. Proc Natl Acad Sci USA 2009;106:12885–12890.
   PubMed Web of Science ®Google Scholar
• Glimelius I, Rubin J, Rostgaard K, et al. Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's lymphoma—a population-based study. Eur J Haematol 2011;87:208–216.
   PubMed Web of Science ®Google Scholar
• Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010;362: 875–885.
   PubMed Web of Science ®Google Scholar
• Louahed J, Zhou Y, Maloy WL, et al. Interleukin 9 promotes influx and local maturation of eosinophils. Blood 2001;97:1035–1042.
   PubMed Web of Science ®Google Scholar
• Molin D, Glimelius B, Sundstrom C, et al. The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease. Leuk Lymphoma 2001;42:457–465.
   PubMed Web of Science ®Google Scholar
• Glimelius I, Edstrom A, Amini RM, et al. IL-9 expression contributes to the cellular composition in Hodgkin lymphoma. Eur J Haematol 2006;76:278–283.
   PubMed Web of Science ®Google Scholar
• Merz H, Lange K, Gaiser T, et al. Characterization of a novel human anaplastic large cell lymphoma cell line tumorigenic in SCID mice. Leuk Lymphoma 2002;43:165–172.
   PubMed Web of Science ®Google Scholar